Publications dans lesquelles il/elle collabore avec Clara Francés Gómez (12)

2023

  1. Antigens from the Helminth Fasciola hepatica Exert Antiviral Effects against SARS-CoV-2 In Vitro

    International Journal of Molecular Sciences, Vol. 24, Núm. 14

  2. Aptamer-Capped Nanoporous Anodic Alumina for SARS-CoV-2 Spike Protein Detection

    Advanced Materials Technologies, Vol. 8, Núm. 11

  3. C-2 Thiophenyl Tryptophan Trimers Inhibit Cellular Entry of SARS-CoV-2 through Interaction with the Viral Spike (S) Protein

    Journal of Medicinal Chemistry, Vol. 66, Núm. 15, pp. 10432-10457

2022

  1. Erratum: The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation (PLoS Pathog (2022) 18:7 (e1010631) DOI: 10.1371/journal.ppat.1010631)

    PLoS Pathogens

  2. Preservation of anti-SARS-CoV-2 neutralising antibodies in convalescent plasma after pathogen reduction with methylene blue and visible light

    Blood Transfusion, Vol. 20, Núm. 3, pp. 206-212

  3. Rapid and direct quantification of the SARS-CoV-2 virus with an ultrasensitive nanobody-based photonic nanosensor

    Sensors and Diagnostics, Vol. 1, Núm. 5, pp. 983-993

  4. The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation

    PLoS Pathogens, Vol. 18, Núm. 7 July

2021

  1. Adoptive transfer of ex vivo expanded SARS-CoV-2-specific cytotoxic lymphocytes: A viable strategy for COVID-19 immunosuppressed patients?

    Transplant Infectious Disease, Vol. 23, Núm. 4

  2. Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2

    mBio, Vol. 12, Núm. 6

  3. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 3, pp. 485-494

  4. Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS-CoV-2 neutralizing activity of sera

    Journal of Medical Virology, Vol. 93, Núm. 4, pp. 2301-2306

2020

  1. SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients

    Journal of Clinical Virology, Vol. 131